Correlation between circ_0092576 and Arterial Stenosis Severity and Inflammatory Status in Patients with Coronary

Wenqin Dai1, Lingli Wang2, Yuan Li3

  • 1Department of Cardiology, Wuhan Wuchang Hospital, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, 430063, Hubei, China.

Folia Biologica
|June 19, 2026
PubMed

Insights

Circular RNA circ_0092576 shows promise as a biomarker for coronary heart disease (CHD). Higher levels predict increased CHD risk, severe stenosis, inflammation, and major adverse cardiac events (MACE).

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Coronary heart disease (CHD) poses a significant global health burden.
  • Identifying reliable biomarkers for CHD risk and prognosis is crucial for early intervention.
  • The role of circular RNAs (circRNAs) in cardiovascular diseases is an emerging area of research.

Purpose of the Study:

  • To evaluate the predictive value of circ_0092576 for CHD and major adverse cardiac events (MACE).
  • To investigate the association between circ_0092576 levels and coronary artery stenosis severity.
  • To explore the relationship between circ_0092576 and inflammatory markers in CHD patients.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) was used to measure plasma levels of circ_0092576, IL-1β, TNF-α, and IL-10.
  • Gensini score system assessed coronary artery stenosis severity.
  • Patient follow-up was conducted to record MACE occurrence.

Main Results:

  • circ_0092576 levels were significantly elevated in CHD patients compared to controls (AUC=0.885).
  • circ_0092576 positively correlated with Gensini scores, IL-1β, and TNF-α, and negatively with IL-10.
  • Higher circ_0092576 levels were associated with increased MACE risk and cumulative incidence.

Conclusions:

  • circ_0092576 is a potential biomarker for CHD risk and prognosis.
  • Elevated circ_0092576 levels indicate higher risk of CHD, more severe coronary artery stenosis, and increased inflammation.
  • circ_0092576 may serve as a predictor for adverse cardiac events in CHD patients.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...